Sleep apnea and related disorders are highly prevalent, requiring increased awareness, collaborative and personalized care with quality diagnostics, and demonstrated value to lessen public health and economic impact. Diagnostic advances will improve access, projecting over 5% industry growth. Desired outcomes include greater awareness, better care, reduced burden, and proven value.